Abstract
Purpose
To evaluate the outcome and complications of sclerotherapy with injection ethanolamine oleate for the treatment of venous malformations (VMs).
Methods
Eighty-three patients' (39 males and 44 females) age ranging from 3 months to 21 years with 85 lesions were followed clinically for about 1 year following treatment with injection of ethanolamine oleate. The cases were enrolled between January 2006 and December 2009. The amount of ethanolamine oleate per treatment session ranged from 0.50 to 10 ml, and maximum dose was 0.40 ml per kg body weight. All patients were evaluated after 8 weeks of last injection session. All of the treatment sessions were performed on a day-case basis.
Results
Eighty-five lesions have under gone 201 sclerotherapy sessions with 39 requiring one, 27 requiring two and 19 lesions requiring more than two sessions. Sclerotherapy with ethanolamine oleate provided complete resolution of symptoms in 79 lesions and significant improvement of 6 lesions. There is no recurrence of studied patients. All patients experienced pain and swelling to a variable degree for short duration. Skin sloughed out in four patients which were healed spontaneously. No other complications were observed in our study.
Conclusion
The treatment of VMs with injection ethanolamine oleate is safe and effective.
Similar content being viewed by others
References
Mulliken JB (1990) Cutaneous vascular anomalies. In: McCarthy JG (ed) Plastic surgery, 1st edn. WB Saunders Company, Philadelphia, pp 3191–3264
Podda S, Duffy FJ (2008) Vascular, venous malformations: updated Sept 11, 2008. http://emedicine.medscape.com/article/1296303-overview. Accessed 11 Sept 2010
Cohen BA (1987) Hemangioma in infancy and childhood. Pediatr Ann 16:17–26
Stringel G (2000) Hemangiomas and lymphangiomas. In: Ashcraft KW (ed) Pediatric surgery, 3rd edn. WB Saunders Company, Philadelphia, pp 965–986
Das BK, Hoque S (2008) Treatment of venous malformation with ethanolamine oleate. Asian J Surg 31:220–224
Das BK, Hoque S (2006) Treatment of craniofacial venous malformation with ethanolamine oleate—a descriptive study of 41 cases. J Surg Sci 10:9–13
Nagata-Narumiya T, Nagai Y, Kashiwagi H, Hama M, Takifuji K, Tanimura H (2000) Endoscopic sclerotherapy for esophageal hemangioma. Gastrointest Endosc 52:285–287
Bemvenuti GA, Julich MM (1998) Ethanolamine injection for sclerotherapy of angiodysplasia of colon. Endoscopy 30:564–569
Nishikawa M, Sakamoto K, Hidaka M, Yamashita A, Yamamoto G (2006) Venous malformation of the tongue in a child treated by sclerotherapy with ethanolamine oleate: a case report. J Pediatr Surg 41:599–600
Berenguer B, Burrows PE, Zurakowski D, Mulliken JB (1999) Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 104:1–11
Kim KH, Sung MW, Roh JL, Han MH (2004) Sclerotherapy for congenital lesions in head and neck. Otolaryngol Head Neck Surg 131:307–316
Mulliken JB, Fishman SJ (1998) Vascular anomalies—hemangiomas and malformation. In: O'Neill JA Jr, Rowe MI, Grosfeld JL, Fonkalsrud EW, Coran AG (eds) Pediatric surgery, 5th edn. Missouri Mosby Year Book Inc., St. Louis, pp 1939–1950
Marrocco-Trischitta MM, Nicodemi EM, Stillo F (2001) Sclerotherapy for venous malformations of the glans penis. Urology 57:310–313
Berthelsen B, Fogdestam I, Sevendeson P (1986) Venous Malformation in the face and neck—radiological diagnosis and treatment with absolute ethanol. Act Radiol Diagn 27:149–155
RxList (2008) The internet drug index, ethanolamine oleate—ethamolin: updated 29 December 2008. http://www.rxlist.com/ethamolin-drug.htm. Accessed 14 Sept 2010
Kishihara F, Ohta M, Hashizume M, Tomikaawa M, Kawanaka H, Tanoue K et al (1999) Systemic effects of ethanolamine oleate in an albuminemic rats. Hepatogastroenterology 46:376–380
Ohta M, Hashizume M, Ueno K, Tanoue K, Sugmachi K (1993) Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy. Hepatogastroenterology 40:65–68
Choi YH, Han MH, O-Ki K, Cha SH, Chang KH (2002) Craniofacial cavernous venous malformations, percutaneous sclerotherapy with use of ethanolomine oleate. J Vasc Interv Radiol 13:475–482
Johnson PL, Eckard DA, Brecheisen MA, Girod DA, Tsue TT (2002) Percutaneous ethanol sclerotherapy of venous malformations of tongue. AJNR Am J Neuroradiol 23:779–782
de Lorimier AA (1995) Sclerotherapy for venous malformations. J Pediatr Surg 30:188–193
Hyodoh H, Fujita A, Hyodoh K, Furuse M, Kamisawa O, Hareyama M (2001) High flow arteriovenous malformation of the lower extremity: ethanolomine oleate sclerotherapy. Cardiovasc Intervent Radiol 24:348–351
Brown B, Sharifi R, Lee M (1995) Ethanolamine sclerotherapy of a renal cyst. J Urol 153:385–386
Tammela TL, Hellstrom PA, Mattila SI, Ottelin PJ, Malinen LJ, Makarainen HP (1992) Ethanolamine oleate sclerotherapy for hydroceles and spermatoceles: a survey of 158 patients with ultrasound follow-up. J Urol 147:1551–1553
Makela JT, Kiviniemi H, Laitinen ST (1996) Randomised trial of endoscopic injection sclerosis with ethanolamine oleate and ethanol for bleeding peptic ulcer. Scand J Gastroenterol 31:1059–1062
Kitano S, Baatar D, Bandoh T, Yoshida T, Tsuboi S, Matsumoto T (2000) Transvenous sclerotherapy for huge oesophagogastric varices using open injection sclerotherapy. Br J Surg 87:926–930
Gasim B, Fedail SS, Musaad AM, Salih SM, Ibn-Ouf M (2002) Endoscopic sclerotherapy for bleeding oesophageal varices: experience in Sudan. Trop Gastroenterol 23:107–109
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoque, S., Das, B.K. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases. Pediatr Surg Int 27, 527–531 (2011). https://doi.org/10.1007/s00383-010-2824-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-010-2824-x